Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5888

Incyte, Prelude ink rare blood cancer pact; Merck takes back rights to Prometheus asset

$
0
0
Plus, news about Kaigene, Celltrion, Solid Bio, Terns Pharmaceuticals, Benitec, Pacira, AmacaThera, UCB, Basilea Pharmaceutica, Pfizer, Kura Oncology, Kyowa Kirin, Novavax, Sanofi, Syndexis and Relmada: 🖊️ Prelude signs Incyte deal, trims pipeline: Prelude will ...

Viewing all articles
Browse latest Browse all 5888

Trending Articles